Effects of repeated administration of (-)-nicotine on AF64A-induced learning and memory impairment in rats

被引:13
作者
Hiramatsu, M [1 ]
Yamatsu, T
Kameyama, T
Nabeshima, T
机构
[1] Meijo Univ, Fac Pharmaceut Sci, Dept Chem Pharmacol, Tenpaku Ku, Nagoya, Aichi 4688503, Japan
[2] Nagoya Univ, Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi, Japan
关键词
(-)-nicotine; neuroprotection; AF64A; learning and memory;
D O I
10.1007/s007020200029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It has been reported that pretreatment with (-)-nicotine prevents glutamate- and amyloid beta protein (Abeta)-induced cytotoxicity in vitro. However, few studies on the neuroprotective effects of (-)-nicotine in vivo have been reported. We examined whether repeated administration of (-)nicotine exhibits neuroprotective effects in AF64A-treated rats. (-)-Nicotine (0.1 and 0.2 mg/kg, s.c.) was administered once a day for 28 days. On day 14, AF64A (2.5nmol/side) was injected bilaterally into the hippocampus. Intrahippocampal injection of AF64A showed severe impairment of learning and memory in rats in the water maze and passive avoidance tests. Repeated administration of (-)-nicotine (0.1 and 0.2mg/kg, s.c.) did not reverse the impairment of memory induced by AF64A in the water maze test. Interestingly, the (-)-nicotine (0.1 and 0.2mg/kg, s.c.)-treated group showed weak impairment of learning and memory after AF64A treatment compared to the (AF64A + saline)-treated group in the passive avoidance test. These results suggested that (-)-nicotine may have neuroprotective effects against the neurotoxicity induced by AF64A.
引用
收藏
页码:361 / 375
页数:15
相关论文
共 49 条
[31]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[33]  
Newhouse P A, 1990, Adv Exp Med Biol, V282, P65
[34]   NICOTINE REVERSES SCOPOLAMINE-INDUCED IMPAIRMENT OF PERFORMANCE IN PASSIVE-AVOIDANCE TASK IN RATS THROUGH ITS ACTION ON THE DOPAMINERGIC NEURONAL SYSTEM [J].
NITTA, A ;
KATONO, Y ;
ITOH, A ;
HASEGAWA, T ;
NABESHIMA, T .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (04) :807-812
[35]   REDUCED NUMBER OF [H-3] NICOTINE AND [H-3] ACETYLCHOLINE BINDING-SITES IN THE FRONTAL-CORTEX OF ALZHEIMER BRAINS [J].
NORDBERG, A ;
WINBLAD, B .
NEUROSCIENCE LETTERS, 1986, 72 (01) :115-119
[36]   Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease [J].
Potter, A ;
Corwin, J ;
Lang, J ;
Piasecki, M ;
Lenox, R ;
Newhouse, PA .
PSYCHOPHARMACOLOGY, 1999, 142 (04) :334-342
[37]  
QUIRION R, 1986, CAN J NEUROL SCI, V13, P503
[38]  
Radcliffe KA, 1998, J NEUROSCI, V18, P7075
[39]   THE EFFECTS OF NICOTINE ON ATTENTION, INFORMATION-PROCESSING, AND SHORT-TERM-MEMORY IN PATIENTS WITH DEMENTIA OF THE ALZHEIMER TYPE [J].
SAHAKIAN, B ;
JONES, G ;
LEVY, R ;
GRAY, J ;
WARBURTON, D .
BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 :797-800
[40]   TAKING STOCK OF COGNITION ENHANCERS [J].
SARTER, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (12) :456-461